GWEP1423: A randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of cannabidiol (GWP42003-P; CBD) as adjunctive treatment for seizures associated with Lennox-Gastaut syndrome in children and

Project: Research project

Project Details

StatusFinished
Effective start/end date7/15/15 → 11/29/18

Funding

  • GW Research Ltd